ÂÜÀòÂÒÂ×

Dale Baird is an experienced executive in the pharmaceutical industry with a strong focus on commercial analytics and business development. Currently serving as Executive Director of Commercial Analytics at KALA BIO since September 2020, Dale leads due diligence efforts, market research, and competitive landscapes for acquisition projects, particularly in orphan and rare diseases. Prior experience includes senior leadership roles at Sunovion Pharmaceuticals and The Janssen Pharmaceutical Companies of Johnson & Johnson, where Dale managed teams and developed strategic plans for various psychiatric and immunological products. Dale's career also includes significant contributions at Boehringer Ingelheim, where strategic market research efforts supported the successful launch of products like nintedanib for idiopathic pulmonary fibrosis. Dale holds an MBA from Regis University.